Page last updated: 2024-12-05

1,3-indandione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,3-Indandione: A Versatile Molecule in Research

**1,3-indandione** is a bicyclic organic compound with the chemical formula C9H6O2. It's a white crystalline solid that melts at 130-132°C. This seemingly simple molecule has gained significant importance in various research areas due to its diverse properties and applications.

**Here's why 1,3-indandione is important for research:**

**1. Pharmacology and Medicinal Chemistry:**

* **Anticoagulant Activity:** 1,3-indandione derivatives, like phenindione and warfarin, are well-known anticoagulants used to prevent blood clotting in patients prone to thrombosis. Their mechanism involves inhibiting vitamin K epoxide reductase (VKOR), a crucial enzyme in the vitamin K cycle that's essential for blood clotting.
* **Anti-cancer Activity:** Research suggests that 1,3-indandione derivatives exhibit anti-cancer activity by targeting various mechanisms, including inhibiting cell growth and promoting apoptosis. These compounds have been investigated for their potential in treating leukemia, breast cancer, and colon cancer.
* **Other Biological Activities:** 1,3-indandione derivatives also demonstrate other promising biological activities like antimicrobial, anti-inflammatory, and anti-diabetic effects.

**2. Organic Chemistry and Materials Science:**

* **Versatile Synthetic Building Block:** 1,3-indandione serves as a valuable building block for synthesizing a wide range of organic compounds, including pharmaceuticals, dyes, and polymers. Its reactivity allows for the introduction of diverse functional groups, leading to novel structures with unique properties.
* **Fluorescence Properties:** Certain 1,3-indandione derivatives exhibit fluorescence, making them suitable for applications in fluorescent probes, sensors, and imaging techniques.
* **Dye Chemistry:** 1,3-indandione derivatives are used in the production of dyes and pigments, contributing to the colorful world we see around us.

**3. Analytical Chemistry:**

* **Chromatographic Applications:** 1,3-indandione derivatives are employed as reagents in high-performance liquid chromatography (HPLC) and gas chromatography (GC) for the separation and analysis of various compounds.
* **Spectroscopic Analysis:** The unique spectroscopic properties of 1,3-indandione derivatives facilitate their identification and quantification using various techniques, including UV-Vis and NMR spectroscopy.

**4. Environmental Science:**

* **Pesticide Degradation:** 1,3-indandione derivatives are used in the synthesis of certain pesticides. Understanding their degradation pathways in the environment is essential for assessing their potential environmental impact.

**Overall, 1,3-indandione remains a crucial molecule in research due to its diverse properties and applications across various disciplines. Ongoing research aims to further explore its potential, leading to the development of novel compounds with improved biological activity, new materials with unique properties, and innovative analytical methods for a brighter future.**

1,3-Indandione is a cyclic diketone compound that has been studied extensively for its diverse pharmacological activities. It is a synthetic compound, typically synthesized via the condensation of phthalic anhydride with ethyl acetate. 1,3-indandione exhibits anti-inflammatory, analgesic, and anti-cancer effects, making it a promising candidate for drug development. Its anti-inflammatory properties are attributed to its ability to inhibit the production of pro-inflammatory cytokines, while its analgesic effects stem from its interaction with opioid receptors. 1,3-indandione has also been investigated for its potential as an anti-cancer agent, showing promising results in inhibiting the growth of various tumor cell lines. The compound's ability to disrupt the production of reactive oxygen species and its induction of apoptosis contribute to its anti-cancer activity. The unique structure of 1,3-indandione allows for various modifications and derivatization, making it a versatile scaffold for the development of novel therapeutic agents. 1,3-indandione has also been investigated for its potential use in other fields, such as in the synthesis of organic dyes and polymers. Further research is ongoing to explore its full potential and to develop new and safer therapeutic applications for this multifaceted compound.'

1,2-indanedione: use for detection of latent fingerprints on porous surfaces; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,3-indandione : A member of the class of indanones that is indane in which the hydrogens at positions 2 and 4 have been replaced by oxo groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID123358
CHEMBL ID235288
SCHEMBL ID669542
MeSH IDM0041650
PubMed CID11815
CHEMBL ID283521
CHEBI ID78877
SCHEMBL ID88188
MeSH IDM0041650

Synonyms (103)

Synonym
indan-1,2-dione
2,3-dihydro-1h-indene-1,2-dione
bdbm22852
1,2-dione-based compound, 9
1,2-indandione
16214-27-0
nsc62555
nsc-62555
1h-indene-1,2(3h)dione
CHEMBL235288
1,2-indanedione
3h-indene-1,2-dione
FT-0659478
1h-indene-1,2(3h)-dione
A810343
indandione
unii-7lzb7qne77
7lzb7qne77 ,
ai3-25041
nsc 62555
AKOS015914972
WFFZGYRTVIPBFN-UHFFFAOYSA-N
indane dione
SCHEMBL669542
SY016747
mfcd00463378
methyl2,4-dioxo-4-pyridin-3-ylbutanoate
DTXSID50167314
indan-1,2-dione, 97%
J-009898
CS-W014296
BBL103322
indane-1,2-dione
STL557132
DS-16394
I0976
Q63617674
PD179174
AC-18310
4djn7yg35g ,
4-07-00-02344 (beilstein handbook reference)
unii-4djn7yg35g
1,3-diketohydrindene
606-23-5
nsc-6312
1h-indene-1,3(2h)-dione
1,3-indandione
nsc6312
nsc-26329
nsc26329
nsc 6312
1,3-indandion
einecs 210-109-7
brn 1210061
1,3-indanone
indan-1,3-dione
nsc 26329
indane-1,3-dione
diketohydrindene
indanedione-1,3
inchi=1/c9h6o2/c10-8-5-9(11)7-4-2-1-3-6(7)8/h1-4h,5h
1,3-indandione, 97%
STK202114
chebi:78877 ,
CHEMBL283521
indene-1,3-dione
I0012
AKOS000119648
3-oxoinden-1-olate;1,3-indandione
A832813
1,3-indanedione
FT-0606736
1,3-dioxoindane
1,3-hydrindendione
2,3-dihydro-1,3-dioxo-1h-indene
SCHEMBL88188
indene-1,3-(2h)dione
DTXSID2060547
indanedione-(1,3)
W-105241
STR03163
2h-indene-1,3-dione
indene-1,3(2h)-dione
1,3-dioxobenzocyclopentane
2-hydrocyclopenta(1,2-a)benzene-1,3-dione
2,3-dihydro-1h-indene-1,3-dione
3-oxo-1-indanone
j7.003c ,
indandione, 1,3-
mfcd00003779
CS-W007948
SY014846
Q161510
AMY25726
AC1334
indane-1
indane 1
indan-1
1.3-indandione
EX-A6026
EN300-18392
1,3-indanedione;1,3-indandione
Z57131040
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
indanones
beta-diketoneA diketone in which the two keto groups are separated by a single carbon atom.
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Coagulation factor XIIHomo sapiens (human)Ki4.44670.00251.86697.2500AID1798260
CholinesteraseHomo sapiens (human)Ki23.19400.00001.51739.7300AID1798260; AID1798261; AID302993
AcetylcholinesteraseHomo sapiens (human)Ki100.00000.00001.27869.7300AID1798261; AID302992
Liver carboxylesterase 1Homo sapiens (human)Ki4.64500.00252.01368.4800AID1798260; AID302991
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (54)

Processvia Protein(s)Taxonomy
plasma kallikrein-kinin cascadeCoagulation factor XIIHomo sapiens (human)
Factor XII activationCoagulation factor XIIHomo sapiens (human)
blood coagulation, intrinsic pathwayCoagulation factor XIIHomo sapiens (human)
positive regulation of plasminogen activationCoagulation factor XIIHomo sapiens (human)
protein processingCoagulation factor XIIHomo sapiens (human)
protein autoprocessingCoagulation factor XIIHomo sapiens (human)
positive regulation of blood coagulationCoagulation factor XIIHomo sapiens (human)
zymogen activationCoagulation factor XIIHomo sapiens (human)
fibrinolysisCoagulation factor XIIHomo sapiens (human)
innate immune responseCoagulation factor XIIHomo sapiens (human)
response to misfolded proteinCoagulation factor XIIHomo sapiens (human)
positive regulation of fibrinolysisCoagulation factor XIIHomo sapiens (human)
blood coagulationCoagulation factor XIIHomo sapiens (human)
xenobiotic metabolic processCholinesteraseHomo sapiens (human)
learningCholinesteraseHomo sapiens (human)
negative regulation of cell population proliferationCholinesteraseHomo sapiens (human)
neuroblast differentiationCholinesteraseHomo sapiens (human)
peptide hormone processingCholinesteraseHomo sapiens (human)
response to alkaloidCholinesteraseHomo sapiens (human)
cocaine metabolic processCholinesteraseHomo sapiens (human)
negative regulation of synaptic transmissionCholinesteraseHomo sapiens (human)
response to glucocorticoidCholinesteraseHomo sapiens (human)
response to folic acidCholinesteraseHomo sapiens (human)
choline metabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
cholesterol biosynthetic processLiver carboxylesterase 1Homo sapiens (human)
cholesterol metabolic processLiver carboxylesterase 1Homo sapiens (human)
response to toxic substanceLiver carboxylesterase 1Homo sapiens (human)
positive regulation of cholesterol effluxLiver carboxylesterase 1Homo sapiens (human)
negative regulation of cholesterol storageLiver carboxylesterase 1Homo sapiens (human)
epithelial cell differentiationLiver carboxylesterase 1Homo sapiens (human)
cholesterol homeostasisLiver carboxylesterase 1Homo sapiens (human)
reverse cholesterol transportLiver carboxylesterase 1Homo sapiens (human)
medium-chain fatty acid metabolic processLiver carboxylesterase 1Homo sapiens (human)
regulation of bile acid biosynthetic processLiver carboxylesterase 1Homo sapiens (human)
cellular response to cholesterolLiver carboxylesterase 1Homo sapiens (human)
cellular response to low-density lipoprotein particle stimulusLiver carboxylesterase 1Homo sapiens (human)
cholesterol ester hydrolysis involved in cholesterol transportLiver carboxylesterase 1Homo sapiens (human)
positive regulation of cholesterol metabolic processLiver carboxylesterase 1Homo sapiens (human)
regulation of bile acid secretionLiver carboxylesterase 1Homo sapiens (human)
lipid catabolic processLiver carboxylesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (22)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityCoagulation factor XIIHomo sapiens (human)
calcium ion bindingCoagulation factor XIIHomo sapiens (human)
protein bindingCoagulation factor XIIHomo sapiens (human)
misfolded protein bindingCoagulation factor XIIHomo sapiens (human)
amyloid-beta bindingCholinesteraseHomo sapiens (human)
catalytic activityCholinesteraseHomo sapiens (human)
acetylcholinesterase activityCholinesteraseHomo sapiens (human)
cholinesterase activityCholinesteraseHomo sapiens (human)
protein bindingCholinesteraseHomo sapiens (human)
hydrolase activity, acting on ester bondsCholinesteraseHomo sapiens (human)
enzyme bindingCholinesteraseHomo sapiens (human)
choline bindingCholinesteraseHomo sapiens (human)
identical protein bindingCholinesteraseHomo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
sterol esterase activityLiver carboxylesterase 1Homo sapiens (human)
methylumbelliferyl-acetate deacetylase activityLiver carboxylesterase 1Homo sapiens (human)
carboxylesterase activityLiver carboxylesterase 1Homo sapiens (human)
carboxylic ester hydrolase activityLiver carboxylesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
extracellular regionCoagulation factor XIIHomo sapiens (human)
extracellular spaceCoagulation factor XIIHomo sapiens (human)
plasma membraneCoagulation factor XIIHomo sapiens (human)
collagen-containing extracellular matrixCoagulation factor XIIHomo sapiens (human)
extracellular exosomeCoagulation factor XIIHomo sapiens (human)
extracellular spaceCoagulation factor XIIHomo sapiens (human)
rough endoplasmic reticulumCoagulation factor XIIHomo sapiens (human)
extracellular regionCholinesteraseHomo sapiens (human)
nuclear envelope lumenCholinesteraseHomo sapiens (human)
endoplasmic reticulum lumenCholinesteraseHomo sapiens (human)
blood microparticleCholinesteraseHomo sapiens (human)
plasma membraneCholinesteraseHomo sapiens (human)
extracellular spaceCholinesteraseHomo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
cytoplasmLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulumLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulum lumenLiver carboxylesterase 1Homo sapiens (human)
lipid dropletLiver carboxylesterase 1Homo sapiens (human)
cytosolLiver carboxylesterase 1Homo sapiens (human)
lipid dropletLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulumLiver carboxylesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1798260Enzyme Inhibition Assay from Article 10.1021/jm0706867: \\Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.\\2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID1798261Cholinesterase Inhibition Assay from Article 10.1021/jm0706867: \\Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.\\2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID302991Inhibition of human carboxylesterase 12007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID302990Inhibition of human intestinal carboxylesterase2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID302992Inhibition of human acetylcholinesterase 12007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID302993Inhibition of human butyrylcholinesterase2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID1145209Antitumor activity against mouse ascites Sarcoma 180 cells allografted in ddN mouse assessed as percentage of total packed cell volume ratio at 100 mg/kg/day for 5 days administered 24 hrs after tumor inoculation measured 7th day after tumor inoculation1976Journal of medicinal chemistry, Mar, Volume: 19, Issue:3
Structure and antitumor activity relationship of 2-arylidene-4-cyclopentene-1, 3-diones and 2-arylideneindan-1, 3-diones.
AID281482Inhibition of human intestinal carboxylesterase expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
AID1553462Cysteine reactivity assessed as cysteine oxidation2019Journal of medicinal chemistry, 06-27, Volume: 62, Issue:12
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
AID109864Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum triglyceride measured on the 16th day1985Journal of medicinal chemistry, Nov, Volume: 28, Issue:11
Hypolipidemic activity of indan-1,3-dione derivatives in rodents.
AID281484Inhibition of rabbit liver carboxylesterase expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
AID109861Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum cholesterol measured on the 16th day1985Journal of medicinal chemistry, Nov, Volume: 28, Issue:11
Hypolipidemic activity of indan-1,3-dione derivatives in rodents.
AID408486Inhibition of recombinant Curvularia lunata trihydroxynaphthalene reductase2008Bioorganic & medicinal chemistry, Jun-01, Volume: 16, Issue:11
Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening.
AID281483Inhibition of human liver CE1 expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
AID109863Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum cholesterol measured on the 9th day1985Journal of medicinal chemistry, Nov, Volume: 28, Issue:11
Hypolipidemic activity of indan-1,3-dione derivatives in rodents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (114)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (17.54)18.7374
1990's1 (0.88)18.2507
2000's27 (23.68)29.6817
2010's46 (40.35)24.3611
2020's20 (17.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.36 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews1 (1.11%)6.00%
Reviews3 (9.68%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies1 (3.23%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other89 (98.89%)84.16%
Other27 (87.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]